Merck & Co. (MRK)
(Delayed Data from NYSE)
$113.92 USD
+1.43 (1.27%)
Updated Aug 8, 2024 04:01 PM ET
After-Market: $113.99 +0.07 (0.06%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth F Momentum C VGM
Brokerage Reports
Merck & Co., Inc. [MRK]
Reports for Purchase
Showing records 181 - 200 ( 399 total )
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for MRK.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for MRK.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for MRK.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for MRK.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for MRK.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for MRK.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Don''t Sleep on New Mechanisms for MDD: A Look at GABA Modulation and Orexin-2 Antagonists
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for MRK.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for MRK.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for MRK.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for MRK.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for MRK.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for MRK.
Provider: Stock Traders Daily
Analyst: Research Department